Molecular structure of TD-139, CAS Number: 1450824-22-2
TD-139 (CAS 1450824-22-2)
Alternate Names:
TD139 olitigaltin TD 139 GB0139 GB-0139 60Y0GUO72B
CAS Number:
1450824-22-2
Molecular Weight:
648.60
Molecular Formula:
C28H30F2N6O8S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
TD-139 (CAS 1450824-22-2) References
- Protocol for in vitro skin fibrosis model to screen the biological effects of antifibrotic compounds. | Alsharabasy, AM. and Pandit, A. 2021. STAR Protoc. 2: 100387. PMID: 33778781
- More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells. | Di Gaetano, S., et al. 2021. Int J Mol Sci. 22: PMID: 34208755
- Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19. | Aminpour, M., et al. 2021. Biomedicines. 9: PMID: 34572394
- Carbohydrate Ligands for COVID-19 Spike Proteins. | Lee, YK., et al. 2022. Viruses. 14: PMID: 35215921
- An Evaluation of the Mechanisms of Galacto-Oligosaccharide (GOS)-Induced IgE Cross-Linking on Basophils in GOS Allergy. | Lee, LYGN., et al. 2022. Front Allergy. 3: 840454. PMID: 35386657
- Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies. | Sethi, A., et al. 2020. RSC Adv. 10: 29873-29884. PMID: 35518264
- Targeting disordered-structured domain interactions in Galectin-3 based on NMR and enhanced MD. | Bhattacharya, S., et al. 2022. Biophys J. 121: 4342-4357. PMID: 36209362
- Epithelial Galectin-3 Induced the Mitochondrial Complex Inhibition and Cell Cycle Arrest of CD8+ T Cells in Severe/Critical COVID-19. | Wang, Y., et al. 2023. Int J Mol Sci. 24: PMID: 37628961
- Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension. | Hadi, DD., et al. 2023. Immun Inflamm Dis. 11: e1079. PMID: 38018591
- Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3. | Schadeck, J., et al. 2023. Front Immunol. 14: 1286097. PMID: 38259448
Inhibitor of:
FIR, galectin-1, galectin-10, galectin-6, galectin-7, galectin-8, GRIFIN, and Mac-2BP.Activator of:
galectin-16.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TD-139, 5 mg | sc-507553 | 5 mg | $739.00 |